Clinical evaluation of medical devices is essential to prove safety, performance, and clinical benefit. At Russell Regulatory Consultants, we prepare clinical evaluation plans (CEPs) and clinical evaluation reports (CERs) that align with UK MDR, EU MDR, and regulatory authority expectations, giving you the evidence regulators can trust.
Clinical Evaluation (Plans and Reports)
Build robust CEPs and CERs for medical device approval
Our Clinical Evaluation Services
We provide flexible, end-to-end support across the full lifecycle of clinical evaluation, from planning to reporting and ongoing updates.
Clinical Evaluation Plan (CEP) Development
Define the scope, methodology, and evidence-gathering process.
Literature Search and Data Collection
Perform structured MEDDEV clinical evaluation searches to support CERs with published studies and post-market data.
Gap Analysis and Evidence Strategy
Identify missing evidence and provide clear recommendations for additional studies, equivalence, or real-world data.
Clinical Evaluation Report (CER) Writing
Compile structured reports assessing clinical safety, performance, residual risks, and clinical benefit.
Lifecycle Updates and Maintenance
Keep CEPs and CERs current with new evidence, post-market surveillance, and regulator feedback.
Regulatory Submission and Reviewer Support
Preparing your CEPs and CERs for submission and ongoing support during regulator or Notified Body reviews.
Why Clinical Evaluation Matters
Medical device evaluation is more than a regulatory checkbox. A strong clinical evaluation:
- Demonstrates your device is safe, effective, and clinically beneficial.
- Supports CE marking and UKCA marking submissions.
- Reduces the risk of regulator pushback, delays, or rejections.
- Provides a clear evidence base for ongoing post-market surveillance.
Without thorough documentation, regulators may challenge your submission, delaying approvals and market access.
Why Choose Russell Regulatory for Clinical Evaluation?
We combine regulatory expertise, real-world submission experience, and a practical approach to deliver clinical evaluation plans and reports that withstand scrutiny.
Regulatory Expertise
In-depth knowledge of EU MDR clinical evaluation, UK MDR, and MEDDEV guidance.
Experienced Leadership
Led by Dr. Amy Russell, with direct Notified Body experience.
End-to-End Service
From CEP drafting to CER updates, we provide scalable solutions for every stage.
Flexible Support Models
Project-based packages or ongoing retainer options tailored to your needs.
Audit-Ready Quality
Documentation formatted and structured for smoother regulator review.
Strategic Value
Beyond compliance, we help build a clinical evidence strategy that supports your long-term market success.
Who Benefits From This Service?
Our clinical evaluation services are designed for:
- Start-ups and SMEs needing clear CEPs and CERs from the start.
- Manufacturers seeking CE marking or UKCA marking with submission-ready documentation.
- Established companies updating evaluations to meet EU MDR clinical evaluation requirements.
- IVD developers building CERs aligned with IVDR expectations.
Ready to Strengthen Your Clinical Evaluation?
From plan to report, Russell Regulatory Consultants ensures your clinical evaluation is structured, compliant, and regulator-ready.
Frequently Asked Questions
Clinical evaluation is the process of assessing clinical data to confirm that a device is safe and performs as intended. It is required for CE and UKCA marking. We support the development of Clinical Evaluation Plans (CEPs), including literature reviews and analysis of existing clinical data. These documents must be updated throughout the product’s lifecycle, especially in response to new evidence or regulatory feedback.
The CEP outlines the methodology and scope of the evaluation, while the CER presents the findings. Both are required under MDR and must be updated as new data emerges or changes occur in the risk profile.
We search medical literature using clear criteria to find relevant clinical data in a consistent and reliable way. This ensures a robust and repeatable process for sourcing relevant clinical data.
Updates are needed when:
- The device undergoes design changes
- New safety/clinical data emerges
- At regular intervals, denied in the CEP
We help track these triggers and update the documentation accordingly.
Yes. We frequently support clients in responding to regulator feedback by refining literature searches, strengthening safety and performance claims, or adding new data analyses.
Stay Informed with Our Latest Insights
Contact Us
We would love to hear from you and discuss how our regulatory affairs specialists can support your regulatory compliance needs.